speb/financial-data huggingface dataset:
Financial ratios for ORTINGLOBE.NS — quarterly report dated 2024-12-31
Total revenue: 3904.884019116447
Gross profit: 198.1582935074018
Operating income: -15759.4125189416
Net income: -12460.659750553677
Capital expenditures: 0
Depreciation & amortization: 244.78377433267278
Owner earnings: -12215.875976221005
Buffett classification: The Gruesome
Stock price: 0.2064343163538874
Shares outstanding: 8131392
Market cap (USD): 1678598.3485254692
COGS to revenue (%): 94.92537313432837
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ORTINGLOBE.NS — quarterly report dated 2025-03-31
Total revenue: 5295.768061725508
Gross profit: 4255.31914893617
Operating income: -18821.603927986904
Net income: -19184.00748187982
Capital expenditures: 0
Depreciation & amortization: 0
Net tangible assets: 231178.39607201307
Owner earnings: -19184.00748187982
Return on net tangible assets (%): -8.298356510745892
Buffett classification: The Gruesome
Stock price: 0.114365736958805
Shares outstanding: 8131392
Book value: 231178.39607201307
P/B ratio: 4.022662387065126
Market cap (USD): 929952.6385809314
Debt to equity: 0.1264222503160556
Current ratio: 2.1516029354963306
Quick ratio: 2.1388567014291233
Interest coverage ratio: -805
COGS to revenue (%): 19.646799116997794
Buyback yield (%): 0
Retained earnings: -794856.207622165
Inventory turnover: 0.44949494949494945
Receivables turnover: 0.17343032159264932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.227833894500561
Revenue growth (%): 35.61908716878549
Rule of 40 score: 35.61908716878549
Financial ratios for ORTINGLOBE.NS — annual report dated 2025-03-31
Total revenue: 40004.67617488894
Gross profit: 14916.997895721299
Operating income: -99836.33387888706
Net income: -98947.8606499883
Capital expenditures: 420.85574000467614
Operating cash flow: -47965.86392331073
Depreciation & amortization: 1367.7811550151976
Net tangible assets: 231178.39607201307
Owner earnings: -98000.93523497778
Return on net tangible assets (%): -42.39190897597977
Buffett classification: The Gruesome
Stock price: 0.114365736958805
Shares outstanding: 8131392
Book value: 231178.39607201307
P/B ratio: 4.022662387065126
Market cap (USD): 929952.6385809314
Debt to equity: 0.1264222503160556
Current ratio: 2.1516029354963306
Quick ratio: 2.1388567014291233
Interest coverage ratio: -316.2962962962963
COGS to revenue (%): 62.71186440677965
SG&A to revenue (%): 45.82115721800117
Free cash flow (dilution-adjusted): -48386.7196633154
Buyback yield (%): 0
Retained earnings: -794856.207622165
Inventory turnover: 10.838383838383837
Receivables turnover: 1.3101071975497702
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.33894500561168
FCF margin (%): -120.95265926358853
Revenue growth (%): -84.20085272922573
Rule of 40 score: -205.15351199281426
Financial ratios for ORTINGLOBE.NS — quarterly report dated 2025-06-30
Total revenue: 4657.149543646151
Gross profit: -795.6938918792418
Operating income: -19014.743739761292
Net income: -20524.221858179266
Capital expenditures: 0
Depreciation & amortization: 0
Owner earnings: -20524.221858179266
Buffett classification: The Gruesome
Stock price: 0.13737421015679852
Shares outstanding: 8131392
Market cap (USD): 1117043.55347531
Interest coverage ratio: -406.24999999999994
COGS to revenue (%): 117.08542713567837
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.059034886646407
Rule of 40 score: -12.059034886646407
Financial ratios for ORTINGLOBE.NS — quarterly report dated 2025-09-30
Total revenue: 1578.3540022547913
Gross profit: 1555.8060879368659
Operating income: -56538.89515219842
Net income: -56651.63472378805
Capital expenditures: 0
Depreciation & amortization: 11.273957158962796
Net tangible assets: 146516.3472378805
Owner earnings: -56640.360766629085
Return on net tangible assets (%): -38.6580486303478
Buffett classification: The Gruesome
Stock price: 0.12874859075535514
Shares outstanding: 8131392
Book value: 146516.34723788052
P/B ratio: 7.145313684210526
Market cap (USD): 1046905.2608793688
Debt to equity: 0.7156048014773776
Current ratio: 2.086131295414683
Quick ratio: 2.080117764971185
Interest coverage ratio: -455.9090909090909
COGS to revenue (%): 1.4285714285714286
Buyback yield (%): 0
Inventory turnover: 0.020833333333333332
Receivables turnover: 0.06216696269982238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.49282382490133
Revenue growth (%): -66.10901180083054
Rule of 40 score: -66.10901180083054
Financial ratios for ORTINGLOBE.NS — quarterly report dated 2025-12-31
Total revenue: 1370.1682076417512
Gross profit: -233.9311574022502
Operating income: -5514.091567338754
Net income: -5926.255987523672
Capital expenditures: 0
Depreciation & amortization: 11.139578923916677
Owner earnings: -5915.116408599755
Buffett classification: The Gruesome
Stock price: 0.1538375849392893
Shares outstanding: 8131392
Market cap (USD): 1250913.7074746576
COGS to revenue (%): 117.07317073170731
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -13.190057130126185
Rule of 40 score: -13.190057130126185
Financial ratios for PGN.DE — annual report dated 2021-12-31
Total revenue: 158787500
Gross profit: 82411363.63636364
Operating income: 5121590.909090909
Net income: -12973863.636363637
Capital expenditures: 10965909.090909092
Operating cash flow: 16827272.727272727
Depreciation & amortization: 18596590.90909091
Net tangible assets: -83075000
Owner earnings: -5343181.818181818
Capex to operating income (%): 214.11138229420902
Buffett classification: The Gruesome
Stock price: 8.159090909090908
Shares outstanding: 4526266
Book value: 3751136.3636363745
P/B ratio: 9.845074183580703
Market cap (USD): 36930215.772727266
Debt to equity: 35.103907906694836
Current ratio: 0.34525408376799827
Quick ratio: 0.1641862135740388
Interest coverage ratio: 0.7544358888516907
COGS to revenue (%): 48.099589932227886
SG&A to revenue (%): 5.002397429383181
Free cash flow (dilution-adjusted): -222727.27272727274
Buyback yield (%): 0
Retained earnings: -18503409.09090909
Inventory turnover: 2.8984001034973477
Receivables turnover: 12.867943641219266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.262206892186954
FCF margin (%): -0.14026751018012926
Rule of 40 score: -0.14026751018012926
Financial ratios for PGN.DE — annual report dated 2022-12-31
Total revenue: 175871276.5957447
Gross profit: 80756382.9787234
Operating income: 1144680.8510638298
Net income: -4461702.127659575
Capital expenditures: 3955319.1489361706
Operating cash flow: 15488297.872340426
Depreciation & amortization: 15190425.531914895
Net tangible assets: -46031914.89361703
Owner earnings: 6773404.255319148
Capex to operating income (%): 345.5390334572491
Buffett classification: The Gruesome
Stock price: 4.585106382978723
Shares outstanding: 4526266
Book value: -175531.91489362717
Market cap (USD): 20753411.127659574
Debt to equity: -724.3515151514733
Current ratio: 0.9128429092696576
Quick ratio: 0.693787457697616
Interest coverage ratio: 0.14185893210283454
COGS to revenue (%): 54.082107924678944
SG&A to revenue (%): 4.738112376677817
Free cash flow (dilution-adjusted): 7270212.765957447
Buyback yield (%): 0
Retained earnings: -21785106.382978726
Inventory turnover: 3.8582833469986624
Receivables turnover: 21.58211488250653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.610151737347739
FCF margin (%): 4.1338261179900675
Revenue growth (%): 10.758892605365473
Rule of 40 score: 14.89271872335554
Financial ratios for PGN.DE — annual report dated 2023-12-31
Total revenue: 193012222.2222222
Gross profit: 93970000
Operating income: 7606666.666666666
Net income: -4235555.555555555
Capital expenditures: 2647777.7777777775
Operating cash flow: -6847777.777777778
Depreciation & amortization: 18257777.777777776
Net tangible assets: -48377777.777777776
Owner earnings: 11374444.444444442
Capex to operating income (%): 34.8086473853345
Buffett classification: The Good
Stock price: 4.266666666666667
Shares outstanding: 4526266
Book value: -4536666.666666672
Market cap (USD): 19312068.266666666
Debt to equity: -17.757776144991407
Current ratio: 0.586038180944476
Quick ratio: 0.28733272173925706
Interest coverage ratio: 0.5410146989094357
COGS to revenue (%): 51.31396399767431
SG&A to revenue (%): 3.1287598367403335
Free cash flow (dilution-adjusted): -15286666.666666666
Buyback yield (%): 0
Retained earnings: -26988888.888888888
Inventory turnover: 4.3454394774045735
Receivables turnover: 26.13767679807403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.18071623961653
FCF margin (%): -7.920051119387949
Revenue growth (%): 9.746301930745322
Rule of 40 score: 1.8262508113573723
Financial ratios for PGN.DE — quarterly report dated 2024-09-30
Total revenue: 35733333.333333336
Gross profit: 20025555.555555556
Operating income: 1934444.4444444445
Net income: 7777.777777777777
Capital expenditures: 1787777.7777777778
Operating cash flow: 6051111.111111111
Depreciation & amortization: 2945555.5555555555
Net tangible assets: -49108888.88888889
Owner earnings: 1165555.5555555557
Return on net tangible assets (%): -2.373410561563872
Capex to operating income (%): 92.41815048822517
Buffett classification: The Gruesome
Stock price: 2.533333333333333
P/E ratio: 368.5673742857143
Shares outstanding: 4526266
Book value: -5682222.222222224
Market cap (USD): 11466540.533333333
Debt to equity: -13.565310911224085
Current ratio: 0.5144217262369284
Quick ratio: 0.2353363508662401
Effective tax rate (%): 97.83950617283949
Interest coverage ratio: 1.2023480662983426
COGS to revenue (%): 43.958333333333336
Free cash flow (dilution-adjusted): 936666.6666666666
Buyback yield (%): 0
Retained earnings: -28104444.444444444
Inventory turnover: 0.7906157373748672
Receivables turnover: 4.8719890925617335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.77561992538951
FCF margin (%): 2.6212686567164174
Rule of 40 score: 2.6212686567164174
Financial ratios for PGN.DE — annual report dated 2024-12-31
Total revenue: 144826041.6666667
Gross profit: 74751041.66666667
Operating income: 7984375
Net income: -6359375
Capital expenditures: 2631250
Operating cash flow: 16627083.333333334
Depreciation & amortization: 17715625
Net tangible assets: -47501041.66666667
Owner earnings: 8725000
Capex to operating income (%): 32.95499021526419
Buffett classification: The Good
Stock price: 2.0208333333333335
Shares outstanding: 4526266
Book value: -10367708.333333328
Market cap (USD): 9146829.208333334
Debt to equity: -6.96794936200141
Current ratio: 0.5248042164190215
Quick ratio: 0.2879581931334306
Interest coverage ratio: 1.1759742252224608
COGS to revenue (%): 48.38563506505649
SG&A to revenue (%): 3.5178698582350947
Free cash flow (dilution-adjusted): 5413541.666666667
Buyback yield (%): 0
Retained earnings: -31661458.333333336
Inventory turnover: 4.228815690218758
Receivables turnover: 25.756391256020752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.605951654842546
FCF margin (%): 3.7379614911567756
Revenue growth (%): -24.9653519351106
Rule of 40 score: -21.227390443953826
Financial ratios for PGN.DE — quarterly report dated 2024-12-31
Total revenue: 30614583.333333336
Gross profit: 16589583.333333334
Operating income: 3903125
Net income: -5313541.666666667
Capital expenditures: 1041.6666666666667
Operating cash flow: 8222916.666666667
Depreciation & amortization: 8356250
Net tangible assets: -47501041.66666667
Owner earnings: 3041666.6666666665
Capex to operating income (%): 0.02668801708033093
Buffett classification: The Great
Stock price: 2.0208333333333335
Shares outstanding: 4526266
Book value: -10367708.333333328
Market cap (USD): 9146829.208333334
Debt to equity: -6.96794936200141
Current ratio: 0.5248042164190215
Quick ratio: 0.2879581931334306
Interest coverage ratio: 2.0419618528610353
COGS to revenue (%): 45.81150051037768
Free cash flow (dilution-adjusted): 4494791.666666667
Buyback yield (%): 0
Retained earnings: -31661458.333333336
Inventory turnover: 0.8463666079959768
Receivables turnover: 5.444609114486847
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.028506307983694
FCF margin (%): 14.681864579789044
Revenue growth (%): -14.324860074626864
Rule of 40 score: 0.3570045051621804
Financial ratios for PGN.DE — quarterly report dated 2025-03-31
Total revenue: 32702173.913043477
Gross profit: 19360869.56521739
Operating income: 2416304.347826087
Net income: 664130.4347826086
Capital expenditures: 47826.086956521736
Operating cash flow: 494565.2173913043
Depreciation & amortization: 2481521.7391304346
Net tangible assets: -49534782.60869565
Owner earnings: 3097826.086956521
Return on net tangible assets (%): -6.253840077240409
Capex to operating income (%): 1.9793072424651372
Buffett classification: The Great
Stock price: 2.5652173913043477
P/E ratio: 4.37069875613748
Shares outstanding: 4526266
Book value: -10298913.043478265
Market cap (USD): 11610856.260869564
Debt to equity: -7.1262269129287565
Current ratio: 0.5254960878231636
Quick ratio: 0.26616190164519676
Effective tax rate (%): 2.2399999999999998
Interest coverage ratio: 1.3859102244389028
COGS to revenue (%): 40.79638370005983
Free cash flow (dilution-adjusted): -1345652.1739130435
Buyback yield (%): 0
Retained earnings: -32373913.043478258
Inventory turnover: 0.7040266146610071
Receivables turnover: 4.679732462280293
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.256879835471551
FCF margin (%): -4.114870703981919
Revenue growth (%): 6.818941669008965
Rule of 40 score: 2.7040709650270465
Financial ratios for PGN.DE — quarterly report dated 2025-06-30
Total revenue: 36292941.17647059
Gross profit: 20203529.411764707
Operating income: 1358823.5294117648
Net income: -715294.1176470588
Capital expenditures: 27058.823529411766
Operating cash flow: 1724705.8823529412
Depreciation & amortization: 3188235.294117647
Net tangible assets: -51611764.705882356
Owner earnings: 2445882.352941177
Capex to operating income (%): 1.9913419913419914
Buffett classification: The Great
Stock price: 2.5764705882352943
Shares outstanding: 4526266
Book value: -9295294.117647052
Market cap (USD): 11661791.223529413
Debt to equity: -8.677762308568543
Current ratio: 0.5720432591651385
Quick ratio: 0.3187692218837085
Interest coverage ratio: 0.6786133960047004
COGS to revenue (%): 44.33206911083017
Free cash flow (dilution-adjusted): 111764.70588235294
Buyback yield (%): 0
Retained earnings: -35755294.11764706
Inventory turnover: 0.7796590844307622
Receivables turnover: 5.872644203312394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.586733743245761
FCF margin (%): 0.30795163538526366
Revenue growth (%): 10.980209673445945
Rule of 40 score: 11.288161308831208
Financial ratios for QFIN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.91
Shares outstanding: 121751884
Market cap (USD): 2180576242.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QFIN — annual report dated 2022-12-31
Total revenue: 2003766091.954023
Net income: 578185775.862069
Capital expenditures: 3875431.0344827585
Operating cash flow: 850936063.2183908
Depreciation & amortization: 11060775.862068966
Net tangible assets: 2563832614.9425287
Owner earnings: 585371120.6896553
Return on net tangible assets (%): 22.831877450891117
Buffett classification: The Gruesome
Stock price: 16.74
P/E ratio: 3.52503749356541
Shares outstanding: 121751884
Book value: 2720013936.7816095
P/B ratio: 0.7493073879509469
Market cap (USD): 2038126538.1599998
Debt to equity: 0.009545251970850172
Effective tax rate (%): 15.53661332345923
COGS to revenue (%): 0
SG&A to revenue (%): 18.784613341601293
Free cash flow (dilution-adjusted): 818362787.3563219
Buyback yield (%): 0
Retained earnings: 1839609770.1149426
Receivables turnover: 1.662687690337053
Capitalized R&D asset: 0
FCF margin (%): 40.84123344747664
Rule of 40 score: 40.84123344747664
Financial ratios for QFIN — annual report dated 2023-12-31
Total revenue: 1885394796.0618846
Net income: 602719549.9296765
Capital expenditures: 11892264.416315049
Operating cash flow: 1001174402.2503515
Depreciation & amortization: 10374402.250351617
Net tangible assets: 2940276933.895921
Owner earnings: 601201687.7637131
Return on net tangible assets (%): 20.447110979002574
Buffett classification: The Gruesome
Stock price: 13.56
P/E ratio: 2.7391770305652576
Shares outstanding: 121751884
Book value: 3095619831.2236285
P/B ratio: 0.5333198638889113
Market cap (USD): 1650955547.04
Debt to equity: 0.03760719572144426
Effective tax rate (%): 19.116690993436034
COGS to revenue (%): 0
SG&A to revenue (%): 17.61233382048416
Free cash flow (dilution-adjusted): 963177496.4838254
Buyback yield (%): 5.419688783407393
Retained earnings: 2292168213.7834034
Receivables turnover: 1.7124367568296748
Capitalized R&D asset: 0
FCF margin (%): 51.08624986637604
Revenue growth (%): -5.907440811951534
Rule of 40 score: 45.17880905442451
Financial ratios for QFIN — annual report dated 2024-12-31
Total revenue: 1922995753.4246576
Net income: 858125205.4794521
Capital expenditures: 20979452.05479452
Operating cash flow: 1279905616.4383562
Depreciation & amortization: 10259452.05479452
Net tangible assets: 3175215479.452055
Owner earnings: 847405205.4794521
Return on net tangible assets (%): 26.68811647471838
Buffett classification: The Gruesome
Stock price: 34.61
P/E ratio: 4.910510352490631
Shares outstanding: 121751884
Book value: 3321399863.013698
P/B ratio: 1.2686917802834332
Market cap (USD): 4213832705.24
Debt to equity: 0.05762535593694011
Effective tax rate (%): 20.83398480213045
COGS to revenue (%): 0
SG&A to revenue (%): 15.496525861581983
Free cash flow (dilution-adjusted): 1235965479.4520547
Buyback yield (%): 9.665466187966963
Retained earnings: 2870183561.6438355
Receivables turnover: 3.1638013840802377
Capitalized R&D asset: 0
FCF margin (%): 64.27291777690759
Revenue growth (%): 1.9943280548621372
Rule of 40 score: 66.26724583176973
Financial ratios for QFIN — quarterly report dated 2024-12-31
Total revenue: 533799726.0273973
Net income: 262553013.69863015
Capital expenditures: 0
Operating cash flow: 418028219.1780822
Net tangible assets: 3175215479.452055
Owner earnings: 262553013.69863015
Return on net tangible assets (%): 8.268825073375453
Buffett classification: The Gruesome
Stock price: 34.61
P/E ratio: 4.012363680270703
Shares outstanding: 121751884
Book value: 3321399863.013698
P/B ratio: 1.2686917802834332
Market cap (USD): 4213832705.24
Debt to equity: 0.05762535593694011
Effective tax rate (%): 1.0369900486829624
COGS to revenue (%): 0
SG&A to revenue (%): 17.450416219925486
Free cash flow (dilution-adjusted): 397048767.1232877
Buyback yield (%): 0
Retained earnings: 2870183561.6438355
Receivables turnover: 0.8782319508607793
Capitalized R&D asset: 0
FCF margin (%): 74.38159814696293
Rule of 40 score: 74.38159814696293
Financial ratios for QFIN — quarterly report dated 2025-03-31
Total revenue: 564606749.3112948
Net income: 247957988.98071626
Capital expenditures: 0
Operating cash flow: 386457988.9807163
Net tangible assets: 3038286501.3774104
Owner earnings: 247957988.98071626
Return on net tangible assets (%): 8.161112813696281
Buffett classification: The Gruesome
Stock price: 40.5
P/E ratio: 4.971559216815032
Shares outstanding: 121751884
Book value: 3184014049.5867767
P/B ratio: 1.5486587763769264
Market cap (USD): 4930951302
Debt to equity: 0.2652695269783944
Effective tax rate (%): 19.08050066884962
COGS to revenue (%): 0
SG&A to revenue (%): 19.223428871846977
Free cash flow (dilution-adjusted): 386457988.9807163
Buyback yield (%): 0
Receivables turnover: 0.9301726870803179
Capitalized R&D asset: 0
FCF margin (%): 68.4472846724054
Revenue growth (%): 5.771269969201211
Rule of 40 score: 74.21855464160662
Financial ratios for QFIN — quarterly report dated 2025-06-30
Total revenue: 603704881.4504882
Net income: 241840167.36401674
Capital expenditures: 0
Operating cash flow: 365690934.44909346
Net tangible assets: 3215981171.548117
Owner earnings: 241840167.36401674
Return on net tangible assets (%): 7.5199497280513965
Buffett classification: The Gruesome
Stock price: 39.84
P/E ratio: 5.014257051909523
Shares outstanding: 121751884
Book value: 3362267921.8967924
P/B ratio: 1.4426557226360421
Market cap (USD): 4850595058.56
Debt to equity: 0.26219123614884204
Effective tax rate (%): 20.327845152925804
COGS to revenue (%): 0
SG&A to revenue (%): 19.372798923615314
Free cash flow (dilution-adjusted): 365690934.44909346
Buyback yield (%): 0
Receivables turnover: 0.9543543800437165
Capitalized R&D asset: 0
FCF margin (%): 60.57445379114181
Revenue growth (%): 6.924843209346182
Rule of 40 score: 67.499297000488
Financial ratios for QFIN — quarterly report dated 2025-09-30
Total revenue: 611183426.9662921
Net income: 201681601.1235955
Capital expenditures: 0
Operating cash flow: 351325140.4494382
Net tangible assets: 3262510393.258427
Owner earnings: 201681601.1235955
Return on net tangible assets (%): 6.18179183552474
Buffett classification: The Gruesome
Stock price: 27.16
P/E ratio: 3.4661085754897023
Shares outstanding: 121751884
Book value: 3413227106.7415733
P/B ratio: 0.9688136962549815
Market cap (USD): 3306781169.44
Debt to equity: 0.2603215753057843
Effective tax rate (%): 21.778795879418663
COGS to revenue (%): 0
SG&A to revenue (%): 18.58231842534262
Free cash flow (dilution-adjusted): 351325140.4494382
Buyback yield (%): 0
Receivables turnover: 0.9308589580414346
Capitalized R&D asset: 0
FCF margin (%): 57.482766211986046
Revenue growth (%): 1.2387750613902022
Rule of 40 score: 58.721541273376246
Financial ratios for QFIN — annual report dated 2025-12-31
Total revenue: 2297395142.857143
Net income: 855670142.8571428
Capital expenditures: 34363142.85714286
Operating cash flow: 1583392571.4285715
Depreciation & amortization: 9731571.42857143
Net tangible assets: 3298923285.714286
Owner earnings: 831038571.4285715
Return on net tangible assets (%): 25.19120632563101
Buffett classification: The Gruesome
Stock price: 18.18
P/E ratio: 2.586802016638254
Shares outstanding: 121751884
Book value: 3451006142.8571424
P/B ratio: 0.6413924402022219
Market cap (USD): 2213449251.12
Debt to equity: 0.1582805892260903
Effective tax rate (%): 18.986799997559693
COGS to revenue (%): 0
SG&A to revenue (%): 19.453870924374847
Free cash flow (dilution-adjusted): 1494976000
Buyback yield (%): 31.289987771328036
Retained earnings: 3500308285.714286
Receivables turnover: 4.54276139054249
Capitalized R&D asset: 0
FCF margin (%): 65.07265433410734
Revenue growth (%): 19.469590027212412
Rule of 40 score: 84.54224436131975
Financial ratios for QFIN — quarterly report dated 2025-12-31
Total revenue: 487003571.4285714
Net income: 145649857.14285713
Capital expenditures: 0
Operating cash flow: 450660571.4285714
Net tangible assets: 3298923285.714286
Owner earnings: 145649857.14285713
Return on net tangible assets (%): 4.415072571513917
Buffett classification: The Gruesome
Stock price: 18.18
P/E ratio: 2.6440938326474828
Shares outstanding: 121751884
Book value: 3451006142.8571424
P/B ratio: 0.6413924402022219
Market cap (USD): 2213449251.12
Debt to equity: 0.1582805892260903
Effective tax rate (%): 11.843218298659822
COGS to revenue (%): 0
SG&A to revenue (%): 20.338718548558607
Free cash flow (dilution-adjusted): 416297428.5714286
Buyback yield (%): 0
Retained earnings: 3500308285.714286
Receivables turnover: 0.9629780180481491
Capitalized R&D asset: 0
FCF margin (%): 85.48139130689862
Revenue growth (%): -20.317935673437276
Rule of 40 score: 65.16345563346134
Financial ratios for RKH.L — annual report dated 2021-12-31
Total revenue: 1133783.783783784
Gross profit: -1309459.4594594594
Operating income: -7370270.27027027
Net income: -10485135.135135135
Capital expenditures: 308108.1081081081
Operating cash flow: -3490540.5405405406
Depreciation & amortization: 1462162.1621621621
Net tangible assets: 208812162.16216215
Owner earnings: -9331081.081081081
Return on net tangible assets (%): -4.468648274344587
Buffett classification: The Gruesome
Stock price: 0.001081081081081081
Shares outstanding: 859723787
Book value: 208812162.16216218
P/B ratio: 0.004451039208910115
Market cap (USD): 929431.1210810811
Debt to equity: 0.007299978643679499
Current ratio: 3.3958880139982504
Quick ratio: 3.3958880139982504
Interest coverage ratio: -1.5790387955993053
COGS to revenue (%): 215.49463647199042
SG&A to revenue (%): 188.55780691299162
Free cash flow (dilution-adjusted): -9301351.35135135
Buyback yield (%): 0
Retained earnings: -131398648.64864865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.130543651925263
FCF margin (%): -820.3814064362335
Rule of 40 score: -820.3814064362335
Financial ratios for RKH.L — annual report dated 2022-12-31
Total revenue: 785542.1686746988
Gross profit: -1581927.7108433736
Operating income: -6451807.2289156625
Net income: 42825301.20481928
Capital expenditures: 0
Operating cash flow: -3077108.43373494
Depreciation & amortization: 146987.95180722894
Net tangible assets: 241526506.0240964
Owner earnings: 42972289.15662651
Return on net tangible assets (%): 17.79195578324612
Buffett classification: The Gruesome
Stock price: 0.0010843373493975904
P/E ratio: 0.0217682207989872
Shares outstanding: 859723787
Book value: 241526506.02409643
P/B ratio: 0.0038597445380037605
Market cap (USD): 932230.6124096386
Debt to equity: 0.002758558765283064
Current ratio: 2.2449400299850075
Quick ratio: 2.2449400299850075
Interest coverage ratio: -1.4639147074904317
COGS to revenue (%): 301.3803680981595
SG&A to revenue (%): 258.74233128834356
Free cash flow (dilution-adjusted): -5715662.65060241
Buyback yield (%): 0
Retained earnings: -72662650.60240965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.0665701881331398
FCF margin (%): -727.6073619631902
Revenue growth (%): -30.714993466117157
Rule of 40 score: -758.3223554293073
Financial ratios for RKH.L — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -49367.08860759493
Operating income: -5156962.025316455
Net income: -5759493.670886076
Capital expenditures: 1636708.8607594937
Operating cash flow: -5583544.303797469
Depreciation & amortization: 49367.08860759493
Net tangible assets: 253316455.69620252
Owner earnings: -7346835.443037975
Return on net tangible assets (%): -2.900259844093544
Buffett classification: The Gruesome
Stock price: 0.0013924050632911392
Shares outstanding: 859723787
Book value: 253316455.69620252
P/B ratio: 0.004725645441235259
Market cap (USD): 1197083.754050633
Debt to equity: 0.0012292624425344794
Current ratio: 1.269435975609756
Quick ratio: 1.269435975609756
Interest coverage ratio: -37.03636363636364
Free cash flow (dilution-adjusted): -7368354.4303797465
Buyback yield (%): 0
Retained earnings: -82321518.98734176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.5706806282722516
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for RKH.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 310471250
Buffett classification: The Gruesome
Stock price: 0.0031249999999999997
Shares outstanding: 859723787
Book value: 310471250
P/B ratio: 0.008653415845670089
Market cap (USD): 2686636.8343749996
Debt to equity: 0.061817318028641946
Current ratio: 10.143835616438356
Quick ratio: 10.143835616438356
Buyback yield (%): 0
Retained earnings: -21777500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RKH.L — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -23750
Operating income: -5537500
Net income: 59515000
Capital expenditures: 2292500
Operating cash flow: 14230000
Depreciation & amortization: 23750
Net tangible assets: 310471250
Owner earnings: 57246250
Return on net tangible assets (%): 18.438502759917384
Buffett classification: The Gruesome
Stock price: 0.0031249999999999997
P/E ratio: 0.0451421798601193
Shares outstanding: 859723787
Book value: 310471250
P/B ratio: 0.008653415845670089
Market cap (USD): 2686636.8343749996
Debt to equity: 0.061817318028641946
Current ratio: 10.143835616438356
Quick ratio: 10.143835616438356
Effective tax rate (%): 39.62099505079448
Interest coverage ratio: -15.068027210884354
Free cash flow (dilution-adjusted): 11842500
Buyback yield (%): 0
Retained earnings: -21777500
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2758665380239909
Rule of 40 score: 0
Financial ratios for RKH.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 274491780.82191783
Buffett classification: The Gruesome
Stock price: 0.006438356164383561
Shares outstanding: 859723787
Book value: 274491780.8219178
P/B ratio: 0.020165295759036625
Market cap (USD): 5535207.94369863
Debt to equity: 0.13761921159402934
Current ratio: 2.0725090373074084
Quick ratio: 2.0725090373074084
Buyback yield (%): 0
Retained earnings: -94780821.91780822
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMI — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.46
Shares outstanding: 6374539
Market cap (USD): 98550372.94000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMI — annual report dated 2022-06-30
Total revenue: -26284332
Net income: -26961060
Capital expenditures: 0
Operating cash flow: -6577886
Net tangible assets: 113228515
Owner earnings: -26961060
Return on net tangible assets (%): -23.811192790084725
Buffett classification: The Gruesome
Stock price: 13.03
Shares outstanding: 6374539
Book value: 113228515
P/B ratio: 0.733562947195766
Market cap (USD): 83060243.17
Debt to equity: 0.7985179351685395
Free cash flow (dilution-adjusted): -6577886
Buyback yield (%): 0
Retained earnings: -11451624
Receivables turnover: -15.857501479608551
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMI — annual report dated 2023-06-30
Total revenue: 867121.02
Net income: 3800728
Capital expenditures: 0
Operating cash flow: 25264979
Net tangible assets: 109349963
Owner earnings: 3800728
Return on net tangible assets (%): 3.475746946526173
Buffett classification: The Gruesome
Stock price: 13.09
P/E ratio: 21.95440334325424
Shares outstanding: 6374539
Book value: 109349963
P/B ratio: 0.7630795038311992
Market cap (USD): 83442715.51
Debt to equity: 0.6714679912603171
COGS to revenue (%): 0
SG&A to revenue (%): 61.959748132965345
Free cash flow (dilution-adjusted): 25264979
Buyback yield (%): 0
Retained earnings: -10238873
Receivables turnover: 0.4551102057997196
Capitalized R&D asset: 0
FCF margin (%): 2913.662385903181
Rule of 40 score: 2913.662385903181
Financial ratios for RMI — annual report dated 2024-06-30
Total revenue: 1103362.59
Net income: 7920583
Capital expenditures: 0
Operating cash flow: 16691564
Net tangible assets: 109854407
Owner earnings: 7920583
Return on net tangible assets (%): 7.210073056058643
Buffett classification: The Gruesome
Stock price: 13.71
P/E ratio: 11.033901126975122
Shares outstanding: 6374539
Book value: 109854407
P/B ratio: 0.7955523321881843
Market cap (USD): 87394929.69000001
Debt to equity: 0.5830899437652965
COGS to revenue (%): 0
SG&A to revenue (%): 59.67856858369649
Free cash flow (dilution-adjusted): 16691564
Buyback yield (%): 0
Retained earnings: -3531353
Receivables turnover: 0.5961589238301997
Capitalized R&D asset: 0
FCF margin (%): 1512.7904599339367
Revenue growth (%): 27.24435973193223
Rule of 40 score: 1540.034819665869
Financial ratios for RMI — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 107573767
Buffett classification: The Gruesome
Stock price: 13.45
Shares outstanding: 6374539
Book value: 107573767
P/B ratio: 0.7970116873382336
Market cap (USD): 85737549.55
Debt to equity: 0.6579671045636991
Buyback yield (%): 0
Retained earnings: -5811993
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RMI — annual report dated 2025-06-30
Total revenue: -2809246
Net income: -3991909
Capital expenditures: 0
Operating cash flow: 9038672
Net tangible assets: 98557276
Owner earnings: -3991909
Return on net tangible assets (%): -4.050344289142082
Buffett classification: The Gruesome
Stock price: 13.23
Shares outstanding: 6374539
Book value: 98557276
P/B ratio: 0.8556968535737535
Market cap (USD): 84335150.97
Debt to equity: 0.6331343816767013
Free cash flow (dilution-adjusted): 9038672
Buyback yield (%): 0
Retained earnings: -9779683
Receivables turnover: -1.4871714242456004
Capitalized R&D asset: 0
Revenue growth (%): -354.6076897531934
Rule of 40 score: -354.6076897531934
Financial ratios for RMI — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 98557276
Buffett classification: The Gruesome
Stock price: 13.23
Shares outstanding: 6374539
Book value: 98557276
P/B ratio: 0.8556968535737535
Market cap (USD): 84335150.97
Debt to equity: 0.6331343816767013
Buyback yield (%): 0
Retained earnings: -9779683
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNTX — annual report dated 2021-12-31
Capital expenditures: 91000
Buffett classification: The Gruesome
Stock price: 11.26
Shares outstanding: 85539032
Market cap (USD): 963169500.3199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -27647000
Net income: -27329000
Capital expenditures: 0
Operating cash flow: -24865000
Depreciation & amortization: 169000
Net tangible assets: 18623000
Owner earnings: -27160000
Return on net tangible assets (%): -145.84116415185525
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 85539032
Book value: 18623000
P/B ratio: 10.885867252322399
Market cap (USD): 202727505.84
Debt to equity: 0.0017720023626698169
Current ratio: 6.463652482269503
Quick ratio: 6.463652482269503
Free cash flow (dilution-adjusted): -26948000
Buyback yield (%): 0
Retained earnings: -272785000
Capitalized R&D asset: 17967000
ROCI (R&D-adjusted, %): -42.823175731074066
Rule of 40 score: 0
Financial ratios for RNTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -15348000
Net income: -15676000
Capital expenditures: 42000
Operating cash flow: -19808000
Depreciation & amortization: 119000
Net tangible assets: -78643000
Owner earnings: -15599000
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 85539032
Book value: 6887000
P/B ratio: 37.882103615507475
Market cap (USD): 260894047.6
Debt to equity: 0.0069696529693625674
Current ratio: 4.1655644241733185
Quick ratio: 4.1655644241733185
Free cash flow (dilution-adjusted): -20998000
Buyback yield (%): 0
Retained earnings: -288517000
Capitalized R&D asset: 16028890
ROCI (R&D-adjusted, %): -15.874231458018508
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.54
Shares outstanding: 85539032
Market cap (USD): 302808173.28000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 85539032
Market cap (USD): 196739773.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -28112000
Net income: -62883000
Capital expenditures: 0
Operating cash flow: -22291000
Depreciation & amortization: 63000
Net tangible assets: -39143000
Owner earnings: -62820000
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 85539032
Book value: 9387000
P/B ratio: 20.958748652391602
Market cap (USD): 196739773.6
Debt to equity: 0
Current ratio: 2.375543572795269
Quick ratio: 2.375543572795269
Free cash flow (dilution-adjusted): -23408000
Buyback yield (%): 0
Retained earnings: -351400000
Capitalized R&D asset: 22851080
ROCI (R&D-adjusted, %): -32.705242019968026
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -5609000
Net income: -5501000
Capital expenditures: 0
Operating cash flow: -6175000
Depreciation & amortization: 0
Net tangible assets: -43656000
Owner earnings: -5501000
Buffett classification: The Gruesome
Stock price: 1.77
Shares outstanding: 85539032
Book value: 4874000
P/B ratio: 31.063620566270004
Market cap (USD): 151404086.64000002
Debt to equity: 0
Current ratio: 1.3938430650828175
Quick ratio: 1.3938430650828175
Free cash flow (dilution-adjusted): -6439000
Buyback yield (%): 0
Retained earnings: -356901000
Capitalized R&D asset: 3054000
ROCI (R&D-adjusted, %): -6.531395667672059
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -6871000
Net income: -6822000
Capital expenditures: 0
Operating cash flow: -6418000
Depreciation & amortization: 1000
Net tangible assets: -45522000
Owner earnings: -6821000
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 85539032
Book value: 3008000
P/B ratio: 39.81204946808511
Market cap (USD): 119754644.8
Debt to equity: 0
Current ratio: 0.8580712243306473
Quick ratio: 0.8580712243306473
Free cash flow (dilution-adjusted): -6674000
Buyback yield (%): 0
Retained earnings: -363723000
Capitalized R&D asset: 6338180
ROCI (R&D-adjusted, %): -8.958271193233644
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -5492000
Net income: -5581000
Capital expenditures: 0
Operating cash flow: -3548000
Depreciation & amortization: 0
Net tangible assets: -47345000
Owner earnings: -5581000
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 85539032
Book value: 1185000
P/B ratio: 82.29071432911392
Market cap (USD): 97514496.47999999
Debt to equity: 0
Current ratio: 0.900766016713092
Quick ratio: 0.900766016713092
Free cash flow (dilution-adjusted): -4995000
Buyback yield (%): 0
Retained earnings: -369304000
Capitalized R&D asset: 5564460
ROCI (R&D-adjusted, %): -12.74136193576037
Rule of 40 score: 0
Financial ratios for RNTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -3959000
Net income: -31967000
Capital expenditures: 0
Operating cash flow: -3220000
Depreciation & amortization: 0
Net tangible assets: -47917000
Owner earnings: -31967000
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 85539032
Book value: -28087000
Market cap (USD): 99225277.11999999
Debt to equity: 0
Current ratio: 0.7
Quick ratio: 0.7
Free cash flow (dilution-adjusted): -3477000
Buyback yield (%): 0
Retained earnings: -401271000
Capitalized R&D asset: 4543630
ROCI (R&D-adjusted, %): -20.495852209631362
Rule of 40 score: 0
Financial ratios for RNTX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -21931000
Net income: -49871000
Capital expenditures: 0
Operating cash flow: -19361000
Depreciation & amortization: 1000
Net tangible assets: -47917000
Owner earnings: -49870000
Buffett classification: The Gruesome
Stock price: 1.16
Shares outstanding: 85539032
Book value: -28087000
Market cap (USD): 99225277.11999999
Debt to equity: 0
Current ratio: 0.7
Quick ratio: 0.7
Free cash flow (dilution-adjusted): -21585000
Buyback yield (%): 0
Retained earnings: -401271000
Capitalized R&D asset: 21892190
ROCI (R&D-adjusted, %): -51.813146614049245
Rule of 40 score: 0
Financial ratios for SANGAMIND.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3271792166688647
Shares outstanding: 49310016
Market cap (USD): 164063260.40880919
Buyback yield (%): 0
Retained earnings: 43412897.27020968
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANGAMIND.NS — annual report dated 2023-03-31
Total revenue: 323551766.1388551
Gross profit: 115628501.8270402
Operating income: 29943970.767356884
Net income: 15900121.80267966
Capital expenditures: 45169305.72472595
Operating cash flow: 26282582.21680877
Depreciation & amortization: 9671132.764920829
Net tangible assets: 107163215.590743
Owner earnings: -19598051.157125458
Return on net tangible assets (%): -18.28803946306589
Capex to operating income (%): 150.84607875040678
Buffett classification: The Gruesome
Stock price: 2.569062119366626
P/E ratio: 7.967265646330626
Shares outstanding: 49310016
Book value: 107568818.51400733
P/B ratio: 1.1776692907942112
Market cap (USD): 126680494.21096224
Debt to equity: 0.9356727132730936
Current ratio: 1.1954850135628938
Quick ratio: 0.6200596318963391
Effective tax rate (%): 18.2387573593887
Interest coverage ratio: 5.132359081419624
COGS to revenue (%): 64.26275053080155
SG&A to revenue (%): 4.613456007468867
Free cash flow (dilution-adjusted): -22493300.852618758
Buyback yield (%): 0
Retained earnings: 55010962.24116931
Inventory turnover: 3.325249337696743
Receivables turnover: 7.528938268805623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.38159284779489
FCF margin (%): -6.951994458582419
Rule of 40 score: -6.951994458582419
Financial ratios for SANGAMIND.NS — annual report dated 2024-03-31
Total revenue: 305828036.93488425
Gross profit: 101230363.35292001
Operating income: 14688811.608106488
Net income: 4895071.3514809925
Capital expenditures: 47135148.09929248
Operating cash flow: 19194147.979374025
Depreciation & amortization: 11609305.672142943
Net tangible assets: 117418155.65415518
Owner earnings: -30630771.075668544
Return on net tangible assets (%): -26.086912117653068
Capex to operating income (%): 320.8915013470487
Buffett classification: The Gruesome
Stock price: 5.241602687140115
P/E ratio: 52.80076505735193
Shares outstanding: 49310016
Book value: 118039333.25338772
P/B ratio: 2.1896388707456897
Market cap (USD): 258463512.36852205
Debt to equity: 1.0829295053488157
Current ratio: 1.2680654205607478
Quick ratio: 0.6424392523364486
Effective tax rate (%): 23.54373478179434
Interest coverage ratio: 1.8850415512465375
COGS to revenue (%): 66.89958044151669
SG&A to revenue (%): 4.801788024938243
Free cash flow (dilution-adjusted): -29766159.011871926
Buyback yield (%): 0
Retained earnings: 57896630.29140185
Inventory turnover: 2.5486839353470168
Receivables turnover: 5.687428915501438
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.383675019440241
FCF margin (%): -9.732972591459829
Revenue growth (%): -5.477865077195887
Rule of 40 score: -15.210837668655715
Financial ratios for SANGAMIND.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 118478260.86956522
Buffett classification: The Gruesome
Stock price: 5.514452938365982
Shares outstanding: 49310016
Book value: 119274964.16626853
P/B ratio: 2.2797555591215435
Market cap (USD): 271917762.6220736
Debt to equity: 1.2013579418568552
Current ratio: 1.3298725193849388
Quick ratio: 0.6891535327597884
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SANGAMIND.NS — annual report dated 2025-03-31
Total revenue: 324248304.88660276
Gross profit: 105704933.36450782
Operating income: 15453588.964227261
Net income: 3717559.0367079726
Capital expenditures: 36404021.51040449
Operating cash flow: 50461772.2702829
Depreciation & amortization: 13384381.575870937
Net tangible assets: 116707972.87818563
Owner earnings: -19302080.89782558
Return on net tangible assets (%): -16.53878515906724
Capex to operating income (%): 235.5700128602769
Buffett classification: The Gruesome
Stock price: 5.034193021356051
P/E ratio: 66.77396000413673
Shares outstanding: 49310016
Book value: 117695814.8234744
P/B ratio: 2.1091330970644213
Market cap (USD): 248236138.43015522
Debt to equity: 1.130168757511646
Current ratio: 1.195187165775401
Quick ratio: 0.6984560979817146
Effective tax rate (%): 28.054298642533936
Interest coverage ratio: 1.5252105688242759
COGS to revenue (%): 67.40000432647587
SG&A to revenue (%): 5.639921835002632
Free cash flow (dilution-adjusted): 13660275.894318447
Buyback yield (%): 0
Retained earnings: 59065934.06593406
Inventory turnover: 3.246028025212273
Receivables turnover: 5.359341487450004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.360859760002227
FCF margin (%): 4.212905877517468
Revenue growth (%): 6.023080204265407
Rule of 40 score: 10.235986081782874
Financial ratios for SANGAMIND.NS — quarterly report dated 2025-03-31
Total revenue: 85842880.52373157
Gross profit: 31133972.41056815
Operating income: 3255786.766425064
Net income: 1112929.6235679213
Capital expenditures: 0
Depreciation & amortization: 3489595.5108721065
Net tangible assets: 116707972.87818563
Owner earnings: 4602525.134440028
Return on net tangible assets (%): 3.9436252904880202
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.034193021356051
P/E ratio: 55.76186786059737
Shares outstanding: 49310016
Book value: 117695814.8234744
P/B ratio: 2.1091330970644213
Market cap (USD): 248236138.43015522
Debt to equity: 1.130168757511646
Current ratio: 1.195187165775401
Quick ratio: 0.6984560979817146
Effective tax rate (%): 25.624999999999996
Interest coverage ratio: 1.0934432665881428
COGS to revenue (%): 63.731444913523084
Buyback yield (%): 0
Retained earnings: 59065934.06593406
Inventory turnover: 0.8125922453161085
Receivables turnover: 1.4188549456070179
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5507976724113928
Rule of 40 score: 0
Financial ratios for SANGAMIND.NS — quarterly report dated 2025-06-30
Total revenue: 92413994.85139248
Gross profit: 33428504.5635385
Operating income: 2545050.3159372807
Net income: 249239.41025040956
Capital expenditures: 0
Depreciation & amortization: 4198455.417739294
Owner earnings: 4447694.827989703
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.650947811841798
P/E ratio: 279.49866228732395
Shares outstanding: 49310016
Market cap (USD): 278648327.01708406
Effective tax rate (%): 15.810276679841898
Interest coverage ratio: 0.7178217821782178
COGS to revenue (%): 63.82744343289818
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.654815737275143
Rule of 40 score: 7.654815737275143
Financial ratios for SANGAMIND.NS — quarterly report dated 2025-09-30
Total revenue: 88633596.3923337
Gross profit: 35574971.8151071
Operating income: 7494926.719278467
Net income: 2607666.2908680947
Capital expenditures: 0
Depreciation & amortization: 1179255.9188275083
Net tangible assets: 114003382.18714769
Owner earnings: 3786922.209695603
Return on net tangible assets (%): 3.3217630363623774
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.896166854565953
P/E ratio: 60.81614127316155
Shares outstanding: 49310016
Book value: 115062006.76437429
P/B ratio: 2.098260518189301
Market cap (USD): 241430065.93731683
Debt to equity: 1.2663433274544384
Current ratio: 1.1537833091547685
Quick ratio: 0.7443765747881196
Effective tax rate (%): 32.13028169014084
Interest coverage ratio: 2.2658486707566463
COGS to revenue (%): 59.862881274008494
Buyback yield (%): 0
Inventory turnover: 0.8777135397239835
Receivables turnover: 1.231620008459574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.628306026437296
Revenue growth (%): -4.090720745421617
Rule of 40 score: -4.090720745421617
Financial ratios for SANGAMIND.NS — quarterly report dated 2025-12-31
Total revenue: 86293862.09201293
Gross profit: 36884259.77498051
Operating income: 6668151.943856522
Net income: 2725854.9626824106
Capital expenditures: 0
Depreciation & amortization: 2731424.7521443693
Owner earnings: 5457279.714826779
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.526456499944302
P/E ratio: 40.69926277050726
Shares outstanding: 49310016
Market cap (USD): 272509658.43555754
Effective tax rate (%): 21.419396274887603
Interest coverage ratio: 2.185469149324571
COGS to revenue (%): 57.257377430098366
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.639782650772758
Rule of 40 score: -2.639782650772758
Financial ratios for SHEMAROO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7855729922194383
Shares outstanding: 28730299
Market cap (USD): 51300045.952789135
Buyback yield (%): 0
Retained earnings: 51116075.43188712
Capitalized R&D asset: 51602.26823157062
Rule of 40 score: 0